房颤抗栓论坛-3 心房颤动与抗凝治疗
Atrial Fibrillation and Antithrombosis Forum-3
11/21 13:30-15:30
308 (308)
-
13:30- 15:30
-
-
13:50-14:10《中国心房颤动管理指南（2025）》更新要点及解读Update Points and Interpretation of the “Chinese Guidelines for the Management of Atrial Fibrillation (2025)”
-
14:30-14:50ESC2025 房颤抗凝前沿：NOAC个体化应用的新增优势证据与启示Frontier of Atrial Fibrillation Anticoagulation at ESC2025: New Advantageous Evidence and Enlightenment for Individualized Application of NOACs
-
14:50-15:10房颤合并冠心病DOAC单药抗凝最新力证Latest Evidence for DOAC Monotherapy Anticoagulation in Atrial Fibrillation Complicated with Coronary Heart Disease
-
14:10-14:30老年房颤伴共病复杂临床，探寻老年科DOACs抗凝优选Complex Clinical Situation of Elderly Atrial Fibrillation with Comorbidities: Exploring the Optimal DOACs Anticoagulation in Geriatrics
-
13:30-13:50主席开场Opening Remarks
-
15:10-15:30讨论Discussion